Active: new fund Sep 2026 Verified 4 Nov 2026
Cultivation Capital
St. Louis, MO venture firm investing from seed through Series B, with strategies in life sciences and health tech, software and IT, agriculture tech, geospatial and Midwest seed stage.
- Type
- VC firm
- Location
- St. Louis, Missouri, United States
- Stages
- Seed, Series A, Series B
- Backs
- B2B software, Medtech and digital health
- Sectors
- Healthtech and life sciences, Biotech, SaaS and software, Agritech, Fintech, AI
- Fund size / AUM
- $100M Cultivation Capital Tech Fund IV (Form D offering, 2022)
- Latest fund or filing
- 24 Sep 2026
- Portfolio mix
- B2B software 60%; Medtech and digital health 24%; Biotech and pharma 11%; Consumer products 4% (n=45, 2019 to 2026)
- Website
- www.cultivationcapital.com
Fund filings (SEC Form D)
- Latest fund on file
- Cultivation Capital AgTech Evergreen Fund
- Filed
- 24 Sep 2026 (new notice)
- Fund size
- $3M (amount sold)
- Fund vehicles filed in the last 12 months
- 2 (includes feeder and parallel vehicles)
See this fund's filings on SEC EDGAR
Contacts on file
For Cultivation Capital, the paid file holds: 8 named decision-makers with roles; LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/2149804/000214980426000001/
- adviserinfo.sec.gov/firm/summary/168734
- cultivationcapital.com/
- www.sec.gov/Archives/edgar/data/1894966/000189496623000001/
- cultivationcapital.com/team/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 64 lists
Series A agritech investors in the US (15)Venture capital firms in Missouri (18)Series B agritech investors (24)Series B biotech investors in the US (34)Series B medtech investors in the US (36)Seed agritech investors in the US (36)Agritech venture capital firms in the US (55)Series B medtech investors (57)Series B fintech investors in the US (59)Series A biotech investors in the US (59)Series A agritech investors (65)Series B healthtech investors in the US (69)Series B biotech investors (73)Series A medtech investors in the US (76)Seed agritech investors (97)Series B SaaS investors in the US (108)Series A medtech investors (125)Series B AI investors in the US (126)Series B fintech investors (127)Agritech investors (137)Series A fintech investors in the US (145)Series A biotech investors (153)Seed biotech investors in the US (159)Series B healthtech investors (160)Series A healthtech investors in the US (164)Series B investors in the US (165)Series B SaaS investors (196)Series B AI investors (204)Seed medtech investors in the US (205)Series A SaaS investors in the US (256)Seed medtech investors (278)Series A AI investors in the US (280)Series A fintech investors (294)Biotech venture capital firms in the US (297)Seed biotech investors (300)Series B investors (339)Seed fintech investors in the US (349)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Seed healthtech investors in the US (437)Medtech investors (457)Series A SaaS investors (475)Biotech investors (484)Series A AI investors (500)Fintech venture capital firms in the US (525)Seed fintech investors (584)Seed SaaS investors in the US (666)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)